Ik Joo Chung
- Hepatology top 2%
-
- Genetic factors in colorectal cancer 3
- Lymphoma Diagnosis and Treatment 3
- Cancer Research top 10%
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 4
- HER2/EGFR in Cancer Research 4
- Cancer survivorship and care 3
-
- Gastric Cancer Management and Outcomes 5
-
- Platelet Disorders and Treatments 3
-
- Immune Cell Function and Interaction 3
Ik Joo Chung
55 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Hepatology 401
- Pathology and Forensic Medicine 332
- Cancer Research 232
- Oncology 352
- Pulmonary and Respiratory Medicine 278
Countries citing papers authored by Ik Joo Chung
This map shows the geographic impact of Ik Joo Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ik Joo Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ik Joo Chung more than expected).
Fields of papers citing papers by Ik Joo Chung
This network shows the impact of papers produced by Ik Joo Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ik Joo Chung. The network helps show where Ik Joo Chung may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ik Joo Chung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2021 | 14 | |
| 4 | 2018 | 34 | |
| 5 | 2016 | 14 | |
| 6 | 2015 | 19 | |
| 7 | 2015 | 8 | |
| 8 | 2014 | 28 | |
| 9 | Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trialbreakdown → | 2014 | 465 |
| 10 | 2013 | 31 | |
| 11 | 2013 | 13 | |
| 12 | 2013 | 24 | |
| 13 | Survival Prediction in Terminally Ill Cancer Patients: Laboratory Variables and Prospective Validation of The Palliative Prognostic Index | 2011 | 3 |
| 14 | 2010 | 63 | |
| 15 | 2009 | 48 | |
| 16 | 2001 | 1 | |
| 17 | 2001 | 35 | |
| 18 | 1999 | 7 | |
| 19 | 1999 | 5 | |
| 20 | 1998 | 2 |
About Ik Joo Chung
Ik Joo Chung is a scholar working on Oncology, Hematology and Genetics, having authored 57 papers that have together received 1.4k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Treatments and Studies (4 papers), HER2/EGFR in Cancer Research (4 papers), Platelet Disorders and Treatments (3 papers), Genetic factors in colorectal cancer (3 papers), Immune Cell Function and Interaction (3 papers), Cancer survivorship and care (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Hepatology (401 citations), Pathology and Forensic Medicine (332 citations) and Cancer Research (232 citations). Ik Joo Chung has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include Yoon‐Koo Kang, Woo Kyun Bae, Jiang Qian, Shukui Qin, Sang‐Hee Cho, Vera Gorbunova, Pei‐Jer Chen, Mark D. McKee, Călin Cainap and Hongming Pan. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.